News Detail

Scieline is proud to announce a new partnership with AVBA-TASGIV, a distinguished leader providing customized solutions and professional services for the pharma, biotech, food and additional industries. Established in 1987, AVBA-TASGIV has built a reputation for delivering precise technological solutions tailored to the unique needs of industries such as pharmaceuticals, biotechnology, semiconductors, electronics and more.

This partnership combines Scieline’s advanced R&D platform with AVBA-TASGIV’s extensive experience and innovative approach. Together, we are set to revolutionize the way R&D teams operate, addressing key challenges including cost escalation, data loss, lengthy development timelines, and excessive administrative burdens.

AVBA-TASGIV’s expertise cover a broad spectrum of technological fields, including pharmaceutical and biotechnological development and manufacturing, surface and microanalysis, x-ray analysis, particle counting, lithography, electron microscopy, and much more. AVBA-TASGIV’s commitment to understanding and fulfilling the complex needs of their clients aligns perfectly with Scieline’s mission to provide process-oriented, data-driven solutions for R&D teams.

“Our collaboration with AVBA-TASGIV represents a powerful synergy that will enhance our ability to deliver comprehensive, cutting-edge solutions to new clients,” said Gai Anbar, the founder and CEO of Scieline. “We are confident this partnership will drive both companies to new heights”.

Through this partnership, Scieline and AVBA-TASGIV aim to provide unparalleled support to R&D teams, ensuring they have the tools and resources necessary to excel in their research endeavors. We look forward to sharing the benefits of this collaboration with our clients and the broader research community in the pharma, biotech, food and chemistry industries.